US 11260120
Immunogenic composition comprising a fusion peptide derived from superantigen toxoids
granted A61KA61K2039/53A61K2039/55505
Quick answer
US patent 11260120 (Immunogenic composition comprising a fusion peptide derived from superantigen toxoids) held by INTEGRATED BIOTHERAPEUTIC VACCINES, INC. expires Mon Feb 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- INTEGRATED BIOTHERAPEUTIC VACCINES, INC.
- Grant date
- Tue Mar 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 44
- CPC classes
- A61K, A61K2039/53, A61K2039/55505, A61K2039/70, A61K39/085